Delivery Order SPE2DB24D1205-SPE2DB24FCQWB
- Not listed
- This federal contract award, valued at $13,408.24, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VYNDAQEL 20 MG CAPSULE UD 120S, a specialty medication. The contract has an ultimate completion date of April 8, 2025 and is a firm fixed-price delivery order. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen...
- This federal contract award is for the pharmaceutical product VYNDAQEL 20 MG CAPSULE UD 120S, awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $12,960.30 firm fixed-price delivery order contract has an ultimate completion date of August 2, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs, particularly within...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of 120 capsules of the medication VYNDAQEL 20 MG. The award, valued at $12,960.30, is a firm fixed-price delivery order contract with a completion date of June 7, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,960.30, is for the delivery of VYNDAQEL 20 MG CAPSULE UD 120S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of August 1, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,784.67 firm fixed-price delivery order is for the supply of 120 capsules of the drug VYNDAQEL 20 MG. The contract has a period of performance through March 28, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award is for the pharmaceutical product VYNDAQEL 20 MG CAPSULE UD 120S, awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA). The $12,960.30 firm fixed-price delivery order has an ultimate completion date of August 2, 2024. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, as well as a $750,000 IDC with the Department...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,960.30 firm-fixed-price delivery order is for the supply of VYNDAQEL 20 MG CAPSULE UD 120S, a specialty medication. The contract has an ultimate completion date of November 15, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,408.24 firm fixed-price delivery order is for the supply of VYNDAQEL 20 MG CAPSULE UD 120S, a pharmaceutical product. The contract has a period of performance through March 31, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The award, valued at $12,960.30, is for the provision of VYNDAQEL 20 MG CAPSULE UD 120S, a specialty pharmaceutical product. The contract is a firm fixed price delivery order with an ultimate completion date of April 16, 2024. Amerisourcebergen Drug Corp, through its Corporate Office...
- This federal contract award, valued at $13,408.24, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award covers the delivery of VYNDAQEL 20 MG CAPSULE UD 120S, a pharmaceutical product, with a completion date of December 27, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, and there was no set-aside designation used. AmerisourceBergen holds a significant...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB24FCQWBDelivery Order
This federal contract award, valued at $12,960.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of VYNDAQEL 20 MG CAPSULE UD 120S. The contract has an ultimate completion date of May 20, 2024 and is a firm fixed-price delivery order. This award is not designated as a set-aside contract. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.0k | 4/29/24 |